BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Map Kinase Kinase 5

Below is an extended Map Kinase Kinase 5 research listing. Click here to return to the Map Kinase Kinase 5 main in depth entry.

Recent Publications on Map Kinase Kinase 5:

Homogeneous time-resolved fluorescence resonance energy transfer assay for measurement of Phox/Bem1p (PB1) domain heterodimerization.
Twenty human proteins encode Phox/Bem1p (PB1) domains, which are involved...
Direct Link
16th August, 2008
Department of Pharmacology and the Lineberger Comprehensive Cancer Center,
Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer.
Abnormal intracellular signaling contributes to carcinogenesis and may...
Direct Link
7th August, 2008
Urology Research Group, Northern Institute for Cancer Research, University
Non-redundant function of the MEK5-ERK5 pathway in thymocyte apoptosis.
The mitogen-activated protein kinases (MAPKs) ERK1/2, p38, and JNK are...
Direct Link
23rd July, 2008
Division of Immunology and Cancer Research Laboratory, Department of
Ethylene signaling is required for the acceleration of cell death induced by the activation of AtMEK5 in Arabidopsis.
Mitogen-activated protein kinases (MAPKs) are involved in the regulation...
Direct Link
17th July, 2008
State Key Laboratory of Plant Physiology and Biochemistry, College of
Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction.
Diabetes mellitus (DM) contributes to the exacerbation of left ventricle...
Direct Link
13th June, 2008
Cardiovascular Research Institute, University of Rochester School of
Fluid shear stress inhibits TNF-mediated JNK activation via MEK5-BMK1 in endothelial cells.
Steady laminar blood flow protects vessels from atherosclerosis. We showed...
Direct Link
13th May, 2008
Aab Cardiovascular Research Institute and Department of Medicine,
HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathway.
The ligand hepatocyte growth factor/scatter factor (HGF) and its receptor...
Direct Link
29th March, 2008
University of Vermont College of Medicine, Department of Pathology, 89
Insight into the binding properties of MEKK3 PB1 to MEK5 PB1 from its solution structure.
MEKK3 is a mitogen-activated protein kinase kinase kinase that...
Direct Link
6th March, 2008
Hefei National Laboratory for Physical Sciences at Microscale and School
Big mitogen-activated protein kinase 1 (BMK1)/extracellular signal regulated kinase 5 (ERK5) is involved in platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell migration. 22nd February, 2008
Department of Pharmacology, The University of Tokushima Graduate School of
A genetic risk factor for periodic limb movements in sleep.
Big mitogen-activated protein kinase 1 (BMK1), also known as extracellular...
Direct Link
30th January, 2008
Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects.
Extracellular signal-regulated kinase 5 (ERK5), the newest member of the...
Direct Link
10th January, 2008
Department of Psychiatry, Psychiatric Institute, University of Illinois at
Fibroblast growth factor 13 is essential for neural differentiation in Xenopus early embryonic development.
In Xenopus embryonic development, the MEK5-ERK5 pathway, one of the MAPK...
Direct Link
20th October, 2007
Department of Cell and Developmental Biology, Graduate School of
Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions.
Restless legs syndrome (RLS) is a frequent neurological disorder...
Direct Link
20th September, 2007
Institute of Human Genetics, GSF National Research Center of Environment
Noncanonical function of MEKK2 and MEK5 PB1 domains for coordinated extracellular signal-regulated kinase 5 and c-Jun N-terminal kinase signaling.
MEKK2 and MEK5 encode Phox/Bem1p (PB1) domains that heterodimerize with...
Direct Link
10th July, 2007
Department of Pharmacology, 1108 Mary Ellen Jones Building, University of
Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms' tumors.
PURPOSE: The most well established molecular markers of poor outcome in...
Direct Link
16th March, 2007
Paediatric Oncology, Institute of Cancer Research/Royal Marsden NHS Trust,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional